Related references
Note: Only part of the references are listed.Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry
Kurt Bestehorn et al.
BMC PUBLIC HEALTH (2009)
Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile
Amanda K. Marma et al.
CIRCULATION (2009)
Secondary prevention of diabetic patients with coronary artery disease in cardiac rehabilitation: risk factors, treatment and target level attainment
H. Voeller et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry
Anselm K. Gitt et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2009)
Cardiovascular protection for all individuals at high risk: evidence-based best practice
George Bakris et al.
CLINICAL RESEARCH IN CARDIOLOGY (2008)
Cardiovascular risk assessment by primary-care physicians in Germany and its lack of agreement with the established risk scores (DETECT)
Sigmund Silber et al.
MEDIZINISCHE KLINIK (2008)
Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Munster (PROCAM) study
G. Assmann et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Rinnonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes: reply
Lars Ryden et al.
EUROPEAN HEART JOURNAL (2007)
Dual cholesterol inhibition with ezetimibe/simvastatin in pre-treated hypercholesterolaemic patients with coronary heart disease or diabetes mellitus: prospective observational cohort studies in clinical practice
Steven K. Hildemann et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
One-year cardiovascular event rates in outpatients with atherothrombosis
Ph. Gabriel Steg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the united states for the diagnosis and treatment of dyslipidemia - Data from National Health and Nutrition Examination Survey 1999 to 2002
Jon G. Keevil et al.
CIRCULATION (2007)
Treatment of hyperlipidemia in primary practise in Germany: Sub-group analyses from the 4E-registry with particular emphasis on men and women with diabetes mellitus
G. Assmann et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2007)
Inadequate medical treatment of patients with coronary artery disease by primary care physicians in Germany
B. Bischoff et al.
CLINICAL RESEARCH IN CARDIOLOGY (2006)
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute
Sidney C. Smith et al.
CIRCULATION (2006)
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
JC Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations
MH Davidson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: The ezetimibe add-on to statin for effectiveness (EASE) trial
TA Pearson et al.
MAYO CLINIC PROCEEDINGS (2005)
National study of physician awareness and adherence to cardiovascular disease prevention guidelines
L Mosca et al.
CIRCULATION (2005)
Excess 1-year cardiovascular risk in elderly primary care patients with a low ankle-brachial index (ABI) and high homocysteine level
S Lange et al.
ATHEROSCLEROSIS (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Quality of lipid-lowering therapy in patients with ischaemic heart disease: a register-based study in 3477 patients
H Kanstrup et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
SM Grundy et al.
CIRCULATION (2004)
High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study
C Diehm et al.
ATHEROSCLEROSIS (2004)
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis
MR Law et al.
BRITISH MEDICAL JOURNAL (2003)
A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization
RJ Valuck et al.
CLINICAL THERAPEUTICS (2003)
Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population:: The gap between treatment guidelines and real life treatment patterns
J Ruof et al.
PREVENTIVE MEDICINE (2002)
Validation of the Framingham Coronary Heart Disease prediction scores - Results of a multiple ethnic groups investigation
RB D'Agostino et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
